Literature DB >> 32871780

Hip Arthroplasty Following Subtotal Sacrectomy for Chordoma.

Matthew R Claxton1, Matthew B Shirley2, Joshua D Johnson2, Kevin I Perry2, Peter S Rose2, Matthew T Houdek3.   

Abstract

BACKGROUND/AIM: Chordomas often affect the sacrum with a high predilection for local-regional recurrence. Patients typically retain their ability to ambulate, and the development of metastatic disease in the periacetabular region can have significant morbidity and pain with ambulation. The purpose of the study was to describe the outcome of patients undergoing a hip arthroplasty following resection of a sacral chordoma. PATIENTS AND METHODS: From 1990 to 2015, 84 patients underwent sacrectomy for chordoma, while four of these (5%) patients underwent hip arthroplasty. The most common level of nerve root sacrifice was S2-5 (n=2). The mean time between sacrectomy and hip arthroplasty was 7 years. Indications for arthroplasty included metastatic disease (n=3) and coxarthrosis (n=1).
RESULTS: Postoperatively two patients ambulated with a gait aid, and no patient had a Trendelenburg gait. The mean Harris Hip Score significantly improved from 49 to 80 postoperatively (p=0.02).
CONCLUSION: The results of this study indicate that hip arthroplasty is a durable treatment option for patients with metastatic disease or coxarthrosis following subtotal sacrectomy for chordoma. Copyright
© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Hip arthroplasty; chordoma; outcome; sacrectomy

Mesh:

Year:  2020        PMID: 32871780      PMCID: PMC7652443          DOI: 10.21873/invivo.12068

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  18 in total

Review 1.  Residual neurological function after sacral root resection during en-bloc sacrectomy: a systematic review.

Authors:  Carmine Zoccali; Jesse Skoch; Apar S Patel; Christina M Walter; Philip Maykowski; Ali A Baaj
Journal:  Eur Spine J       Date:  2016-02-25       Impact factor: 3.134

2.  Low dose radiotherapy is associated with local complications but not disease control in sacral chordoma.

Authors:  Matthew T Houdek; Peter S Rose; Mario Hevesi; Joseph H Schwab; Anthony M Griffin; John H Healey; Ivy A Petersen; Thomas F DeLaney; Peter W Chung; Michael J Yaszemski; Jay S Wunder; Francis J Hornicek; Patrick J Boland; Franklin H Sim; Peter C Ferguson
Journal:  J Surg Oncol       Date:  2019-02-07       Impact factor: 3.454

3.  The outcome of surgical treatment for peri-acetabular metastases.

Authors:  M Shahid; T Saunders; L Jeys; R Grimer
Journal:  Bone Joint J       Date:  2014-01       Impact factor: 5.082

4.  How Does the Level of Sacral Resection for Primary Malignant Bone Tumors Affect Physical and Mental Health, Pain, Mobility, Incontinence, and Sexual Function?

Authors:  Rishabh Phukan; Tyler Herzog; Patrick J Boland; John Healey; Peter Rose; Franklin H Sim; Michael Yazsemski; Kathryn Hess; Polina Osler; Thomas F DeLaney; Yen-Lin Chen; Francis Hornicek; Joseph Schwab
Journal:  Clin Orthop Relat Res       Date:  2016-03       Impact factor: 4.176

5.  Definitive high-dose photon/proton radiotherapy for unresected mobile spine and sacral chordomas.

Authors:  Yen-Lin Chen; Norbert Liebsch; Wendy Kobayashi; Saveli Goldberg; David Kirsch; Geoffrey Calkins; Stephanie Childs; Joseph Schwab; Francis Hornicek; Thomas DeLaney
Journal:  Spine (Phila Pa 1976)       Date:  2013-07-01       Impact factor: 3.468

6.  Prognostic factors in surgical resection of sacral chordoma.

Authors:  Andrea Angelini; Elisa Pala; Teresa Calabrò; Marco Maraldi; Pietro Ruggieri
Journal:  J Surg Oncol       Date:  2015-08-04       Impact factor: 3.454

7.  The surgical management of sacral chordomas.

Authors:  Joseph H Schwab; John H Healey; Peter Rose; Jorge Casas-Ganem; Patrick J Boland
Journal:  Spine (Phila Pa 1976)       Date:  2009-11-15       Impact factor: 3.468

8.  Maintenance of bowel, bladder, and motor functions after sacrectomy.

Authors:  Dane Moran; Patricia L Zadnik; Tessa Taylor; Mari L Groves; Alp Yurter; Jean-Paul Wolinsky; Timothy F Witham; Ali Bydon; Ziya L Gokaslan; Daniel M Sciubba
Journal:  Spine J       Date:  2014-09-06       Impact factor: 4.166

9.  A comparative study for wide excision of malignant tumors distal to S2.

Authors:  Shunzo Osaka; Hiromi Matsuzaki; Eiji Osaka; Yukihiro Yoshida; Junnosuke Ryu
Journal:  Anticancer Res       Date:  2008 Nov-Dec       Impact factor: 2.480

10.  Comparison of Porous Tantalum Acetabular Implants and Harrington Reconstruction for Metastatic Disease of the Acetabulum.

Authors:  Matthew T Houdek; Peter C Ferguson; Matthew P Abdel; Anthony M Griffin; Mario Hevesi; Kevin I Perry; Peter S Rose; Jay S Wunder; David G Lewallen
Journal:  J Bone Joint Surg Am       Date:  2020-07-15       Impact factor: 6.558

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.